Results 151 to 160 of about 3,332 (178)

Case report: anti-fibrillarin autoantibodies induced by viral molecular mimicry in a paediatric patient. [PDF]

Ital J Pediatr
Autilio C, Pecoraro R, Pafundi V, Manieri S, Tipo V, Martemucci L, Carbone T.   +6 more
europepmc   +1 more source

Innovations in immunotherapy for autoimmune diseases: recent breakthroughs and future directions. [PDF]

Front Immunol
Alsayb MA.
europepmc   +1 more source

Use of Glucagon-Like Peptide-1 (GLP-1) Agonists in Modulating Preexisting Dermatologic Disease: A Systematic Review. [PDF]

Cureus
Tassavor B, Al Salem S.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Systemic therapy in juvenile localized scleroderma

Expert Review of Clinical Immunology, 2023
Juvenile localized scleroderma (JLS) is a rare sclerosing disorder of childhood which can result in permanent morbidity and functional disability, if not effectively treated. Treatment should be started in the inflammatory phase before the development of any complication and/or damage.In this review, we will discuss how to assess disease activity and ...
Ivan Foeldvari, Edoardo Marrani
openaire   +2 more sources

Predictors of family impact of juvenile localized scleroderma

Pediatric Dermatology, 2021
AbstractObjectiveTo measure the impact juvenile localized scleroderma (jLS) has on family quality of life and to identify predictors of family impact in this population which may inform the development of tailored resources to enhance family functioning for patients with jLS.MethodsA retrospective cohort study of pediatric patients with jLS and their ...
Katia Milovanova, Merna Adly, Brendan C. Lethebe, Rebeka Stevenson, Vimal H. Prajapati, Nadia J. C. Luca   +5 more
openaire   +2 more sources

Juvenile localized scleroderma: A single‐centre experience from India

Journal of the European Academy of Dermatology and Venereology, 2022
AbstractBackgroundJuvenile localized scleroderma (JLS) or morphoea, a rare chronic autoimmune disease predominantly affects skin, subcutaneous tissue and occasionally the adjacent muscle, fascia and bone. We report the largest single‐centre cohort of patients with JLS from India.MethodsPatients who were diagnosed to have JLS were enrolled from the ...
Ankur Kumar Jindal, Sanjeev Handa, Sathish Kumar Loganathan, Murugan Sudhakar, Akanksha Kaushik, Deepti Suri, Vignesh Pandiarajan, Amit Rawat, Anju Gupta, Dipankar De, Rahul Mahajan, Surjit Singh   +11 more
openaire   +2 more sources

BILATERAL CHOROIDAL EXCAVATION IN JUVENILE LOCALIZED SCLERODERMA

RETINAL Cases & Brief Reports, 2018
Purpose: To describe a case of bilateral choroidal excavation in a patient with juvenile localized scleroderma. Methods: Case report. Results: An asymptomatic 12-year-old boy with localized scleroderma presented for examination and was ...
Mackenzie L, Franklin, Shelley, Day
openaire   +2 more sources

Musculoskeletal MRI findings of juvenile localized scleroderma

Pediatric Radiology, 2017
Juvenile localized scleroderma comprises a group of autoimmune conditions often characterized clinically by an area of skin hardening. In addition to superficial changes in the skin and subcutaneous tissues, juvenile localized scleroderma may involve the deep soft tissues, bones and joints, possibly resulting in functional impairment and pain in ...
Eric P, Eutsler, Daniel B, Horton, Monica, Epelman, Terri, Finkel, Lauren W, Averill   +4 more
openaire   +2 more sources

Overview of Juvenile localized scleroderma and its management

World Journal of Pediatrics, 2019
Juvenile localized scleroderma (JLS) is a rare pediatric disease characterized by inflammation and skin thickening. JLS is associated with deep tissue and extracutaneous involvement that often results in functional impairment and growth disturbances.
Suzanne C. Li, Rong-Jun Zheng
openaire   +2 more sources